Search

Your search keyword '"Target therapies"' showing total 235 results

Search Constraints

Start Over You searched for: Descriptor "Target therapies" Remove constraint Descriptor: "Target therapies" Topic target therapies Remove constraint Topic: target therapies
235 results on '"Target therapies"'

Search Results

1. The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer.

2. Outcomes of Radiotherapy in Oligoprogressive Breast Cancer.

3. Highlights on Future Treatments of IPF: Clues and Pitfalls.

4. Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies.

5. CD44: A New Prognostic Marker in Colorectal Cancer?

6. Principles in the Management of Glioblastoma.

7. Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors

8. The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis.

9. Advancing the Management of Skull Base Chondrosarcomas: A Systematic Review of Targeted Therapies.

10. A Systematic Review of the Metabolism of High-Grade Gliomas: Current Targeted Therapies and Future Perspectives.

11. Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives.

12. Optimizing the Continuum of Care in Gastric Cancer.

13. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.

14. "De Novo" Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature.

15. Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment.

16. Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease

19. Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications.

20. Immunotherapy for diffuse large B-cell lymphoma: current use of immune checkpoint inhibitors therapy.

21. The use of epidermal growth factor receptor in cancer treatment.

22. Hereditary spastic paraplegias proteome: common pathways and pathogenetic mechanisms.

23. Carbon Nanotubes for Biomedical Applications

25. Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications

26. Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA.

28. Ovarian cancer – where are we today?

29. MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies.

30. Impact of Oral Mesenchymal Stem Cells Applications as a Promising Therapeutic Target in the Therapy of Periodontal Disease.

31. Prevention and Therapy of Metastatic HER-2 + Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine.

33. Precision medicine: The use of tailored therapy in primary immunodeficiencies

34. Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment

35. Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents.

36. Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa—Possibilities and Limitations.

37. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study.

38. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study

39. Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia.

41. The Evolving Role of Allogeneic Stem Cell Transplant in the Era of Molecularly Targeted Agents.

42. Bullous Pemphygoid and Novel Therapeutic Approaches

43. Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine

44. Progress of MRI Radiomics in Hepatocellular Carcinoma

45. Progress of MRI Radiomics in Hepatocellular Carcinoma.

46. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.

47. Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours.

49. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.

50. Novel therapeutic approaches for cutaneous T cell lymphomas.

Catalog

Books, media, physical & digital resources